España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
AstraZeneca
AZN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$65.19
0.4
0.62%
At close: -
$65.12
-0.07
-0.11%
After Hours: 5:02 PM EDT
Get Report
Comment
Q3 2024 earnings were released today before the market open
Today's conference call ended over 13 hours ago
Click to view the webcast
AstraZeneca (AZN) Forecast
News
Earnings
AstraZeneca (AZN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for AstraZeneca (NASDAQ:AZN) Stock
AstraZeneca Stock (NASDAQ: AZN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 12, 2024
AstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It Takes China Investigations 'Very Seriously'
Vandana Singh
AstraZeneca CEO Says Too Early To Judge Wheth...
Benzinga Newsdesk
AstraZeneca Commits $3.5B Investment To Expan...
Benzinga Newsdesk
AstraZeneca Announces $3.5B Of Capital Invest...
Benzinga Newsdesk
AstraZeneca's High-Level Results From KOMET P...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
AstraZeneca Raised Its 2024 Guidance: Now Exp...
Benzinga Newsdesk
AstraZeneca Q3 2024 Adj. EPADS $1.04 Beats $1...
Benzinga Newsdesk
Daiichi Sankyo And AstraZeneca Submit New BLA...
Benzinga Newsdesk
Monday, November 11, 2024
The Week Kamala Harris Lost (Nov 4-8), These Large Cap Stocks Lost Big
Lekha Gupta
A Closer Look at AstraZeneca's Options Market Dynamics
Benzinga Insights
AstraZeneca Q3 Earnings Preview: Will Cancer, Heart Drugs Fuel Continued Growth?
Henry Khederian
Friday, November 08, 2024
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
Vandana Singh
Astrazeneca Says TEZSPIRE Met Both Co-primary...
Benzinga Newsdesk
Amgen And AstraZeneca Report Phase 3 Results:...
Benzinga Newsdesk
Wednesday, November 06, 2024
AstraZeneca Says Arrests Of Current And Forme...
Benzinga Newsdesk
Tuesday, November 05, 2024
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
Vandana Singh
Why Is AstraZeneca Stock Sinking On Tuesday?
Vandana Singh
AstraZeneca Comments On Share Price Movement;...
Benzinga Newsdesk
AstraZeneca shares are trading lower followin...
Benzinga Newsdesk
Reported Earlier, 'AstraZeneca Insurance Frau...
Benzinga Newsdesk
Monday, November 04, 2024
Smart Money Is Betting Big In AZN Options
Benzinga Insights
AstraZeneca Unveils Early Data From Chinese-Firm Partnered Oral Weight Loss Drug
Vandana Singh
AstraZeneca Meet The Management: Weight Manag...
Benzinga Newsdesk
'AstraZeneca Says Experimental Obesity Pill S...
Benzinga Newsdesk
Wednesday, October 30, 2024
Reported Earlier, 'Novo Nordisk's Ozempic and...
Benzinga Newsdesk
AstraZeneca China President Under Investigati...
Benzinga Newsdesk
Daiichi Sankyo And AstraZeneca Launch Three P...
Benzinga Newsdesk
Monday, October 28, 2024
AstraZeneca shares are trading higher. The Eu...
Benzinga Newsdesk
Earlier On Monday, The European Union Approve...
Benzinga Newsdesk
Friday, October 25, 2024
Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises 2024 Forecast
Vandana Singh
Thursday, October 24, 2024
Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder
Vandana Singh
Monopar Therapeutics Has Entered Into An Agre...
Benzinga Newsdesk
Wednesday, October 23, 2024
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
Vandana Singh
Monday, October 21, 2024
Ionis And AstraZeneca's WAINZUA Recommended F...
Benzinga Newsdesk
Monday, October 14, 2024
AstraZeneca And Daiichi Sankyo's Enhertu (Tra...
Benzinga Newsdesk
Friday, October 11, 2024
GSK Settles Majority Of Zantac Lawsuits, But Pipeline Doubts Remain
Vandana Singh
AstraZeneca Reports 9.9% Passive Stake In Con...
Benzinga Newsdesk
Wednesday, October 09, 2024
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Vandana Singh
Tuesday, October 08, 2024
AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline
Zacks
Monday, October 07, 2024
Dow Tumbles Over 400 Points; Duckhorn Portfolio Shares Surge
Avi Kapoor
Crude Oil Gains Over 3%; Scholar Rock Shares Spike Higher
Avi Kapoor
US Stocks Open Lower; Dow Tumbles Over 150 Points
Avi Kapoor
AstraZeneca Inks $1.92B License Pact With Hong Kong-Based Firm To Boost Cardiovascular Pipeline
Vandana Singh
AstraZeneca Says High-level Results From BATU...
Benzinga Newsdesk
Astrazeneca Entered Into An Exclusive License...
Benzinga Newsdesk
Friday, October 04, 2024
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
Vandana Singh
Thursday, October 03, 2024
AstraZeneca Seeks Expanded Use For Blood Cancer Drug Calquence, FDA Grants Priority Review
Vandana Singh
The FDA Has Accepted And Granted Priority Rev...
Benzinga Newsdesk
Wednesday, October 02, 2024
Arcus Biosciences Announces Clinical Trial Co...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch